RIGEL PHARMACEUTICALS INC 4
4 · RIGEL PHARMACEUTICALS INC · Filed Apr 6, 2016
Insider Transaction Report
Form 4
VANCE DOLLY
SVP, Gen. Counsel, Corp. Sec.
Transactions
- Award
Employee Stock Option (right to buy)
2016-04-04+62,500→ 62,500 totalExercise: $3.59Exp: 2024-02-27→ Common Stock (62,500 underlying) - Award
Employee Stock Option (right to buy)
2016-04-04+175,000→ 175,000 totalExercise: $2.14Exp: 2025-01-26→ Common Stock (175,000 underlying)
Footnotes (2)
- [F1]On February 27, 2014, the reporting person was granted an option to purchase 62,500 shares of common stock. The option vests based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 4, 2016, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option.
- [F2]On January 26, 2015, the reporting person was granted an option to purchase 175,000 shares of common stock. The option vests based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 4, 2016, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option.